Science and Technology Committee
19 May 2026
No chapters available yet
Legend
Transcript markers
- text Sentence being played
- text Search result
- text Intervention cited by the link you opened
Click a sentence to play the video from that moment. Select text to quote it with the speaker, timestamp and link.
More options
Science and Technology Committee House of Lords
00:03 - 01:03
Speaker 8
Good morning. Welcome to this select committee on science and technology where we're continuing our inquiry on innovation in the NHS, personalized medicines, and AI. We're very pleased to have two witnesses in our first session, professor Peter Donnelly, who's the CEO of Genomics, plc, and doctor Christian Itin, who's the CEO of Autolus Therapeutics. So you're both very welcome. I'd like to start by asking you both to set out briefly for us what your companies do, what their main products are, and the journey that they've had so far towards wider use in the NHS.
And perhaps you could say what benefits will these technologies provide for patients, and importantly, how soon. So, sir Peter, would you like to start?
01:03 - 02:15
Speaker 16
Thank you very much. And, firstly, let me thank you very much for your interest and the invitation to give evidence this morning. I was an academic for most of my professional career, became an entrepreneur rather late in life. I led the Wilkom Centre for Human Genetics in Oxford, and I was lucky enough to be part of many of the major discoveries of the early two thousands, which transformed our knowledge of the way genetics plays in to all the common diseases, heart disease, diabetes, and so As academics, we used to talk about the impact this was going to have on patients and on health care, and it slowly dawned on me and a number of colleagues that actually wasn't having any impact despite what we wrote in our grant applications. And so in 2014, we formed Genomics.
It was a spin out from the Welcome Center in Oxford with a vision of continuing to do outstanding science, but to develop the products and technologies to make a difference in health and health care. So Genomics is now 12 years old. We employ about a 140 people. We raise over a £100,000,000 from investors both in The UK and The US. We operate in two divisions.
The rest of the transcript is for Pro customers
Unlock the full transcript, chat, and every analysis feature with Polyfact Pro.
The video itself stays free to watch, in full, no account needed.
Ask anything about this video — I analyse its transcript to answer.